NFA
CLVS

Nationwide Fund Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Nationwide Fund Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-161,958
Closed -$13.3M – 2414
2017
Q3 		$13.3M Buy
161,958
+44,530
+38% +$3.53M 0.05% 485
2017
Q2 		$11M Buy
117,428
+74,558
+174% +$4.56M 0.04% 596
2017
Q1 		$2.73M Buy
42,870
+4,485
+12% +$273K 0.01% 1270
2016
Q4 		$1.71M Buy
38,385
+17,762
+86% +$625K 0.01% 1484
2016
Q3 		$743K Hold
20,623
– – ﹤0.01% 1961
2016
Q2 		$283K Buy
20,623
+2,754
+15% +$40.3K ﹤0.01% 2441
2016
Q1 		$343K Sell
17,869
-524
-3% -$11.1K ﹤0.01% 2286
2015
Q4 		$644K Sell
18,393
-81,796
-82% -$5.28M ﹤0.01% 1974
2015
Q3 		$9.21M Buy
100,189
+84,063
+521% +$7.27M 0.04% 566
2015
Q2 		$1.42M Sell
16,126
-18,100
-53% -$1.55M 0.01% 1654
2015
Q1 		$2.54M Buy
34,226
+13,483
+65% +$952K 0.01% 1327
2014
Q4 		$1.16M Sell
20,743
-255
-1% -$13.4K 0.01% 1727
2014
Q3 		$952K Buy
20,998
+25
+0.1% +$1.04K ﹤0.01% 1852
2014
Q2 		$868K Buy
20,973
+5,636
+37% +$290K ﹤0.01% 1948
2014
Q1 		$1.06M Buy
15,337
+1,479
+11% +$109K ﹤0.01% 1705
2013
Q4 		$835K Buy
13,858
+1,154
+9% +$62.8K ﹤0.01% 1972
2013
Q3 		$772K Buy
12,704
+2,264
+22% +$161K ﹤0.01% 1982
2013
Q2 		$699K Buy
+10,440
New +$469K ﹤0.01% 1853

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Nationwide Fund Advisors's CLVS Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q4 2017, closing a stake of 161,958 shares — an estimated $13.3M sold.

Nationwide Fund Advisors first reported a position in CLVS in Q2 2013 and held it in 18 quarters. The position peaked at $13.3M in Q3 2017. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Clovis Oncology, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 161,958 Clovis Oncology, Inc. shares in Q4 2017, an estimated $13.3M.
  • Nationwide Fund Advisors first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Clovis Oncology, Inc. position peaked at $13.3M in Q3 2017.
  • 247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.